ZyCoV-D

COVID-19: Zydus Cadila gets DGCI nod for phase 3 clinical trials with biological therapy

COVID-19: Zydus Cadila gets DGCI nod for phase 3 clinical trials with biological therapy

The trials, which will commence in December, will be conducted on 250 patients across 20-25 centres in India, according to the filing.

PM Modi's visit has encouraged us in doing more, doing fast: Zydus Cadila chairperson

PM Modi's visit has encouraged us in doing more, doing fast: Zydus Cadila chairperson

"The scientists, all 18,000 of them and 25,000 plus Ziduns are continuously thriving and working for providing safe and efficacious vacci...Read More

Covishield, Covaxin & ZyCov-D top COVID-19 vaccine contenders. When will India get a vaccine?

Covishield, Covaxin & ZyCov-D top COVID-19 vaccine contenders. When will India get a vaccine?

In India, top contenders are Covishield, Covaxin and ZyCov-D. And, there is a new hope that India can get a vaccine soon. But, who will s...Read More

Vaccines can’t be express delivered

Vaccines can’t be express delivered

Declaring a date for its (COVAXIN) “public health use” is assuming the outcome of the clinical trial like ‘match-fixing’ in cricket – fro...Read More

ICMR plans to launch indigenous COVID-19 vaccine by mid-August; experts remain skeptical

ICMR plans to launch indigenous COVID-19 vaccine by mid-August; experts remain skeptical

India's apex medical body ICMR said Friday that it aims to launch the world's first COVID-19 vaccine, the indigenously developed Covaxin,...Read More

Free Press Journal

www.freepressjournal.in